SRDX

SRDX

USD

Surmodics Inc. Common Stock

$28.690+0.230 (0.808%)

Reaalajas hind

Healthcare
Meditsiiniseadmed
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$28.460

Kõrge

$29.100

Madal

$28.460

Maht

0.07M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

410.2M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

0.09M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $26Praegune $28.690Kõrge $42.44

Seotud uudised

Analyst Upgrades

Needham Reiterates Hold on Surmodicsto Hold

Needham analyst Mike Matson reiterates Surmodics from Hold to Hold.

Vaata rohkem
Needham Reiterates Hold on Surmodicsto Hold
BusinessWire

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30

Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that second quarter of fiscal year 2025 financial results will be

Vaata rohkem
Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
BusinessWire

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon

European Journal of Vascular and Endovascular Surgery Publishes Results Showing Comparable Safety and Efficacy of SurVeil™ DCB Despite IN.PACT™ Admiral™ DCB having 75% Higher Paclitaxel

Vaata rohkem
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon